APA (7th ed.) Citation

LHD, L., AM, F., LC, R., M, C., E, P., H, L., . . . AK, M. (2025). Noradrenergic signaling controls Alzheimer's disease pathology via activation of microglial β2 adrenergic receptors. Brain, behavior, and immunity, 128, 307. https://doi.org/10.1016/j.bbi.2025.04.022

Chicago Style (17th ed.) Citation

LHD, Le, et al. "Noradrenergic Signaling Controls Alzheimer's Disease Pathology via Activation of Microglial β2 Adrenergic Receptors." Brain, Behavior, and Immunity 128 (2025): 307. https://doi.org/10.1016/j.bbi.2025.04.022.

MLA (9th ed.) Citation

LHD, Le, et al. "Noradrenergic Signaling Controls Alzheimer's Disease Pathology via Activation of Microglial β2 Adrenergic Receptors." Brain, Behavior, and Immunity, vol. 128, 2025, p. 307, https://doi.org/10.1016/j.bbi.2025.04.022.